Jazz Pharmaceuticals plc (JAZZ)
USD 102.82
(-3.84%)
USD 102.82
(-3.84%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.44 Billion USD | 16.78% |
| 2022 | 553.78 Million USD | 59.68% |
| 2021 | 1.02 Billion USD | -32.1% |
| 2020 | 649.65 Million USD | 2.8% |
| 2019 | 1.01 Billion USD | 16.05% |
| 2018 | 932.66 Million USD | 12.18% |
| 2017 | 778.99 Million USD | 6.76% |
| 2016 | 753.88 Million USD | 12.46% |
| 2015 | 665.97 Million USD | 13.07% |
| 2014 | 583.7 Million USD | 33.56% |
| 2013 | 454.11 Million USD | 55.25% |
| 2012 | 268.45 Million USD | 98.73% |
| 2011 | 136.9 Million USD | 75.74% |
| 2010 | 54.21 Million USD | 230.07% |
| 2009 | 15.93 Million USD | 123.66% |
| 2008 | -125.57 Million USD | -1.49% |
| 2007 | -128.25 Million USD | -0.06% |
| 2006 | -67.74 Million USD | -232.92% |
| 2005 | -51.7 Million USD | -18.95% |
| 2004 | -24.8 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 239.59 Million USD | -31.8% |
| 2024 Q2 | 362.47 Million USD | 34.98% |
| 2023 Q2 | 317.21 Million USD | 14.58% |
| 2023 FY | - USD | 16.78% |
| 2023 Q4 | 361.42 Million USD | 7.9% |
| 2023 Q3 | 334.95 Million USD | 5.59% |
| 2023 Q1 | 276.84 Million USD | 11.18% |
| 2022 Q2 | 310.89 Million USD | 16.33% |
| 2022 Q1 | 267.26 Million USD | 29.32% |
| 2022 FY | - USD | 59.68% |
| 2022 Q4 | 249 Million USD | -18.95% |
| 2022 Q3 | 307.23 Million USD | -1.18% |
| 2021 Q3 | 195.94 Million USD | 152.1% |
| 2021 Q1 | 235.09 Million USD | -14.97% |
| 2021 Q2 | 77.72 Million USD | -66.94% |
| 2021 Q4 | 206.67 Million USD | 5.47% |
| 2021 FY | - USD | -32.1% |
| 2020 Q3 | 277.7 Million USD | 5.15% |
| 2020 FY | - USD | 2.8% |
| 2020 Q4 | 276.48 Million USD | -0.44% |
| 2020 Q1 | 216.08 Million USD | -7.94% |
| 2020 Q2 | 264.1 Million USD | 22.22% |
| 2019 FY | - USD | 16.05% |
| 2019 Q2 | 268.05 Million USD | 7.15% |
| 2019 Q3 | 251.73 Million USD | -6.09% |
| 2019 Q4 | 234.73 Million USD | -6.75% |
| 2019 Q1 | 250.16 Million USD | 8.02% |
| 2018 FY | - USD | 12.18% |
| 2018 Q4 | 231.59 Million USD | -3.37% |
| 2018 Q3 | 239.67 Million USD | -5.93% |
| 2018 Q2 | 254.78 Million USD | 76.28% |
| 2018 Q1 | 144.53 Million USD | -28.49% |
| 2017 Q1 | 164.93 Million USD | -13.95% |
| 2017 FY | - USD | 6.76% |
| 2017 Q4 | 202.1 Million USD | -4.59% |
| 2017 Q3 | 211.83 Million USD | 7.9% |
| 2017 Q2 | 196.32 Million USD | 19.03% |
| 2016 FY | - USD | 12.46% |
| 2016 Q1 | 155.08 Million USD | -4.18% |
| 2016 Q4 | 191.66 Million USD | 5.99% |
| 2016 Q3 | 180.82 Million USD | -8.67% |
| 2016 Q2 | 197.98 Million USD | 27.67% |
| 2015 Q3 | 160.2 Million USD | -9.47% |
| 2015 FY | - USD | 13.07% |
| 2015 Q1 | 143.66 Million USD | -15.03% |
| 2015 Q2 | 176.96 Million USD | 23.18% |
| 2015 Q4 | 161.84 Million USD | 1.02% |
| 2014 Q2 | 141.75 Million USD | 52.7% |
| 2014 FY | - USD | 33.56% |
| 2014 Q1 | 92.83 Million USD | -19.98% |
| 2014 Q4 | 169.08 Million USD | 2.14% |
| 2014 Q3 | 165.53 Million USD | 16.78% |
| 2013 Q4 | 116 Million USD | -4.14% |
| 2013 FY | - USD | 55.25% |
| 2013 Q2 | 97.06 Million USD | 9.9% |
| 2013 Q1 | 88.31 Million USD | -1.66% |
| 2013 Q3 | 121.01 Million USD | 24.68% |
| 2012 Q2 | 51.43 Million USD | 9.55% |
| 2012 FY | - USD | 98.73% |
| 2012 Q1 | 46.95 Million USD | 18.02% |
| 2012 Q4 | 89.8 Million USD | 19.67% |
| 2012 Q3 | 75.04 Million USD | 45.89% |
| 2011 Q1 | 24.46 Million USD | -11.25% |
| 2011 Q2 | 35.72 Million USD | 46.0% |
| 2011 Q3 | 36.66 Million USD | 2.64% |
| 2011 Q4 | 39.78 Million USD | 8.52% |
| 2011 FY | - USD | 75.74% |
| 2010 FY | - USD | 230.07% |
| 2010 Q2 | 25.13 Million USD | 170.68% |
| 2010 Q1 | 9.28 Million USD | -32.7% |
| 2010 Q4 | 27.57 Million USD | 67.16% |
| 2010 Q3 | 16.49 Million USD | -34.38% |
| 2009 Q3 | 5.76 Million USD | -43.62% |
| 2009 Q4 | 13.79 Million USD | 139.32% |
| 2009 FY | - USD | 123.66% |
| 2009 Q2 | 10.22 Million USD | 299.36% |
| 2009 Q1 | -5.12 Million USD | -144.18% |
| 2008 Q3 | -27.58 Million USD | 35.28% |
| 2008 Q4 | 11.6 Million USD | 142.09% |
| 2008 Q1 | -41.15 Million USD | -12.4% |
| 2008 Q2 | -42.62 Million USD | -3.57% |
| 2008 FY | - USD | -1.49% |
| 2007 Q1 | -18.93 Million USD | 82.98% |
| 2007 Q4 | -36.61 Million USD | -141.52% |
| 2007 Q2 | -45.04 Million USD | -137.88% |
| 2007 Q3 | -15.15 Million USD | 66.35% |
| 2007 FY | - USD | -0.06% |
| 2006 Q4 | -111.23 Million USD | -1052.93% |
| 2006 FY | - USD | -232.92% |
| 2006 Q1 | 9.83 Million USD | 113.43% |
| 2006 Q2 | 11.67 Million USD | 18.66% |
| 2006 Q3 | 11.67 Million USD | 0.0% |
| 2005 Q4 | -73.22 Million USD | -1465.9% |
| 2005 Q2 | 5.36 Million USD | 0.0% |
| 2005 FY | - USD | -18.95% |
| 2005 Q1 | 5.36 Million USD | 0.0% |
| 2005 Q3 | 5.36 Million USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -6.86 Million USD | 21203.99% |
| Jaguar Health, Inc. | -33.13 Million USD | 4474.821% |
| Keros Therapeutics, Inc. | -152.17 Million USD | 1052.458% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | 2653.868% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | 661.265% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | -1324.815% |
| ContextLogic Inc. | -324 Million USD | 547.352% |
| MiMedx Group, Inc. | 40.51 Million USD | -3477.318% |
| MEI Pharma, Inc. | 26.38 Million USD | -5394.397% |
| AlloVir, Inc. | -190.14 Million USD | 862.268% |
| Novavax, Inc. | -487.39 Million USD | 397.384% |
| Aptorum Group Limited | -9.59 Million USD | 15199.723% |
| Ardelyx, Inc. | -55.35 Million USD | 2718.459% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | 925.073% |
| Psyence Biomedical Ltd. | -2.75 Million USD | 52775.99% |
| Vaxcyte, Inc. | -464.88 Million USD | 411.781% |
| Precigen, Inc. | -89.22 Million USD | 1724.439% |
| Pharming Group N.V. | 9.87 Million USD | -14574.719% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | 1011.305% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | 6467.727% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | 8635.551% |
| Avidity Biosciences, Inc. | -233.49 Million USD | 720.745% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | 8164.239% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | 6111.231% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | 6111.231% |
| Bicycle Therapeutics plc | -183.4 Million USD | 890.306% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | 1757.865% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | 5104.392% |
| Acelyrin, Inc. | -381.52 Million USD | 479.901% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | -273892.817% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | 4441.407% |
| Senti Biosciences, Inc. | -61.33 Million USD | 2463.085% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | 1390.624% |
| AbCellera Biologics Inc. | -192.15 Million USD | 854.287% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | 4790.079% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | 976.202% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | 451633.333% |
| Chimerix, Inc. | -92.97 Million USD | 1658.954% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | 4566.219% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 7289.95% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | 3361.768% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | 3192.958% |
| Elevation Oncology, Inc. | -41.46 Million USD | 3595.363% |
| Alkermes plc | 495.04 Million USD | -192.784% |
| Fortress Biotech, Inc. | -133.64 Million USD | 1184.548% |
| Fortress Biotech, Inc. | -133.64 Million USD | 1184.548% |
| Agenus Inc. | -145.92 Million USD | 1093.272% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | 1974.018% |
| Dyadic International, Inc. | -8.22 Million USD | 17712.004% |
| ImmuCell Corporation | -2.5 Million USD | 57982.485% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | 498183.162% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | 1211.341% |
| Lantern Pharma Inc. | -15.78 Million USD | 9281.292% |
| Immix Biopharma, Inc. | -16.13 Million USD | 9082.734% |
| Incyte Corporation | 919.42 Million USD | -57.644% |
| IO Biotech, Inc. | -91.22 Million USD | 1688.791% |
| Janux Therapeutics, Inc. | -71.02 Million USD | 2140.75% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | 7378.994% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | 2626.185% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | 1022.054% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | 17363.244% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | 2037.345% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 481.458% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 368.447% |
| NextCure, Inc. | -59.03 Million USD | 2555.025% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | 14640.75% |
| Onconetix, Inc. | -36.7 Million USD | 4048.655% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | -64751.096% |
| Opthea Limited | -200.01 Million USD | 824.643% |
| PDS Biotechnology Corporation | -40.08 Million USD | 3715.874% |
| PureTech Health plc | -11.62 Million USD | 12566.002% |
| Pyxis Oncology, Inc. | -78.49 Million USD | 1946.562% |
| Seer, Inc. | -97.88 Million USD | 1580.74% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | 11249105.618% |
| Clearside Biomedical, Inc. | -23.05 Million USD | 6385.983% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | 23796.74% |
| VYNE Therapeutics Inc. | -29.25 Million USD | 5053.934% |
| Wave Life Sciences Ltd. | -58.79 Million USD | 2565.423% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | 6206.686% |
| C4 Therapeutics, Inc. | -122.1 Million USD | 1287.049% |
| ChromaDex Corporation | -3.89 Million USD | 37321.931% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | 21154.939% |
| Caribou Biosciences, Inc. | -112.53 Million USD | 1387.986% |
| CRISPR Therapeutics AG | -202.7 Million USD | 815.054% |
| Precision BioSciences, Inc. | -32.04 Million USD | 4623.507% |
| Fate Therapeutics, Inc. | -172.22 Million USD | 941.567% |
| Innoviva, Inc. | 248.96 Million USD | -482.191% |
| Summit Therapeutics Inc. | 1 Million USD | -144697.403% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | 2430.373% |
| Aadi Bioscience, Inc. | -65.36 Million USD | 2317.428% |
| ESSA Pharma Inc. | -26.45 Million USD | 5578.757% |
| GlycoMimetics, Inc. | -39.12 Million USD | 3804.878% |
| GT Biopharma, Inc. | 5.97 Million USD | -24141.88% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | 801.244% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | -1569.61% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | 2929.852% |
| Alzamend Neuro, Inc. | -9.88 Million USD | 14760.017% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | 712.547% |
| Aptose Biosciences Inc. | -52.26 Million USD | 2873.058% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | 1445.254% |
| Soligenix, Inc. | -7.85 Million USD | 18557.273% |
| Century Therapeutics, Inc. | -121.2 Million USD | 1295.814% |
| Kura Oncology, Inc. | -164.95 Million USD | 978.677% |
| TScan Therapeutics, Inc. | -80.09 Million USD | 1909.561% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | 14470.633% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | 151437.891% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | 33737.085% |
| Autolus Therapeutics plc | -156.77 Million USD | 1024.553% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | 1812.111% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | 2200.581% |
| Eterna Therapeutics Inc. | -19.93 Million USD | 7371.105% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | 865.784% |
| GRI Bio, Inc. | -10.89 Million USD | 13399.89% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | 32197.287% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | 1283.144% |
| IGM Biosciences, Inc. | -253.35 Million USD | 672.085% |
| INmune Bio, Inc. | - USD | -Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | 1496.468% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | 3900.943% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | 9554.248% |
| Entero Therapeutics, Inc. | -15.74 Million USD | 9306.63% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | 2649.779% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | 1453.297% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | 644.902% |
| Coherus BioSciences, Inc. | -193.93 Million USD | 847.36% |
| Verastem, Inc. | -83.16 Million USD | 1842.806% |
| Abeona Therapeutics Inc. | -50.57 Million USD | 2966.056% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | 1016.034% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | 1370.431% |
| Histogen Inc. | -10.5 Million USD | 13900.076% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | 10250.222% |
| Surrozen, Inc. | -41.13 Million USD | 3623.916% |
| Organovo Holdings, Inc. | -14.8 Million USD | 9889.423% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | -45195472.186% |
| Ovid Therapeutics Inc. | -58.71 Million USD | 2568.648% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | 2925.715% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | 6829.291% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | 17483.319% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | 972.798% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | 3042.483% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | 6097.774% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | 9727.488% |
| Apollomics, Inc. | -171.74 Million USD | 943.929% |
| Amarin Corporation plc | -50.9 Million USD | 2947.502% |
| Mesoblast Limited | -61.33 Million USD | 2463.278% |
| Turnstone Biologics Corp. | -56.23 Million USD | 2677.483% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | 1112.159% |
| Synaptogenix, Inc. | -8.3 Million USD | 17547.135% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | 9549.26% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | 2398.955% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 30350.074% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | -337729.894% |
| Exelixis, Inc. | 196.6 Million USD | -637.237% |
| Better Therapeutics, Inc. | -38.26 Million USD | 3888.15% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | 1124.986% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 392.688% |
| NLS Pharmaceutics AG | -11.79 Million USD | 12387.762% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | -586197.812% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | 5012.296% |
| Gritstone bio, Inc. | -126.86 Million USD | 1242.51% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | 2330.395% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | 36336.039% |
| Avid Bioservices, Inc. | -11.48 Million USD | 12724.527% |
| Insmed Incorporated | -654.73 Million USD | 321.374% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | 64526.802% |
| MediWound Ltd. | -4.89 Million USD | 29722.358% |
| OmniAb, Inc. | -49.73 Million USD | 3014.524% |
| Alector, Inc. | -142.89 Million USD | 1114.348% |
| Seres Therapeutics, Inc. | -85.43 Million USD | 1796.54% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | 2879.439% |
| Zai Lab Limited | -366.57 Million USD | 495.398% |
| Revance Therapeutics, Inc. | -290.63 Million USD | 598.705% |
| Aura Biosciences, Inc. | -83.69 Million USD | 1831.77% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | 743.475% |
| Immunic, Inc. | -99.11 Million USD | 1562.408% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | 1200.799% |
| Veracyte, Inc. | -49.4 Million USD | 3033.518% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | 20618.632% |
| FibroGen, Inc. | -261.4 Million USD | 654.474% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | 13109.802% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | 20802.101% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | 7843.935% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | 5801.448% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | -3533.547% |
| TG Therapeutics, Inc. | 26.1 Million USD | -5453.341% |
| Galecto, Inc. | -37.51 Million USD | 3963.168% |
| Calithera Biosciences, Inc. | -38.26 Million USD | 3887.853% |
| Fortrea Holdings Inc. | 167.3 Million USD | -766.361% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | 1179.403% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | 5219.643% |
| XBiotech Inc. | -35.76 Million USD | 4152.514% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | 2330.395% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | 2321.336% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | 1487.604% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | 5745.926% |
| Theravance Biopharma, Inc. | -40.86 Million USD | 3646.681% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 380.649% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | 2687.283% |
| Vaxxinity, Inc. | -56.05 Thousand USD | 2585998.557% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | 1345.904% |
| Gain Therapeutics, Inc. | -22.16 Million USD | 6637.894% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | 716.607% |
| NexImmune, Inc. | -28.16 Million USD | 5245.723% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | 26331.281% |
| Marker Therapeutics, Inc. | -11.79 Million USD | 12391.287% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 68.858% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | 5808.184% |
| Scopus BioPharma Inc. | -11.71 Million USD | 12474.315% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | 1251.743% |
| Ainos, Inc. | -8.77 Million USD | 16621.211% |
| Pluri Inc. | -20.22 Million USD | 7266.487% |
| Prothena Corporation plc | -190.1 Million USD | 862.42% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | 1230.612% |
| Celularity Inc. | -183.94 Million USD | 887.961% |
| Rallybio Corporation | -72.37 Million USD | 2102.711% |
| Cue Biopharma, Inc. | -46.05 Million USD | 3247.36% |
| MeiraGTx Holdings plc | -57.05 Million USD | 2640.528% |
| Omeros Corporation | -163.61 Million USD | 985.901% |
| Humacyte, Inc. | -96.45 Million USD | 1602.646% |
| Immunocore Holdings plc | -59.64 Million USD | 2529.918% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | 7582.046% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | 6048.787% |
| Blueprint Medicines Corporation | -474.61 Million USD | 405.391% |
| CalciMedica, Inc. | -34.18 Million USD | 4339.44% |
| Cabaletta Bio, Inc. | -73.23 Million USD | 2079.165% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | 1254.946% |
| Scholar Rock Holding Corporation | -168.45 Million USD | 960.441% |
| Sana Biotechnology, Inc. | -252.39 Million USD | 674.279% |
| Pulmatrix, Inc. | -12.64 Million USD | 11561.506% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | 4496.718% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | 1738.376% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 386.269% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | 1532.023% |
| Cytokinetics, Incorporated | -456.68 Million USD | 417.38% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | 4443.098% |
| Nutriband Inc. | -5.12 Million USD | 28399.202% |
| Protara Therapeutics, Inc. | -43.27 Million USD | 3449.561% |
| Vor Biopharma Inc. | -114.37 Million USD | 1367.299% |
| Roivant Sciences Ltd. | -996.51 Million USD | 245.449% |
| Evogene Ltd. | -23.2 Million USD | 6346.432% |
| ProKidney Corp. | -147.66 Million USD | 1081.534% |
| Applied Therapeutics, Inc. | -64.53 Million USD | 2345.947% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | 946512.97% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 356.323% |
| CorMedix Inc. | -48.88 Million USD | 3064.839% |
| BioLineRx Ltd. | -57.06 Million USD | 2640.127% |
| Tango Therapeutics, Inc. | -111.75 Million USD | 1396.929% |
| Galectin Therapeutics Inc. | -202 Thousand USD | 717635.644% |
| Atai Life Sciences N.V. | -36.31 Million USD | 4091.688% |
| Renovaro Biosciences Inc. | -79.51 Million USD | 1922.783% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | 1882.522% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | 626.1% |
| Sagimet Biosciences Inc. | -30.74 Million USD | 4815.101% |
| MediciNova, Inc. | -9.87 Million USD | 14770.308% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | 1250.874% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | 94821.02% |
| GeoVax Labs, Inc. | -26.66 Million USD | 5534.904% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | 744.213% |
| Biomea Fusion, Inc. | -124.62 Million USD | 1263.073% |
| PTC Therapeutics, Inc. | -330.34 Million USD | 538.767% |
| Mereo BioPharma Group plc | -26.05 Million USD | 5662.719% |
| Cullinan Oncology, Inc. | -190.33 Million USD | 861.495% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | 730.342% |
| Absci Corporation | -95.45 Million USD | 1618.403% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | 4927.384% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | 1453.108% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | 720.801% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | 6441.816% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | 797.387% |
| Allakos Inc. | -189.91 Million USD | 863.195% |
| Imunon, Inc. | -19.87 Million USD | 7391.486% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | 1435.971% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | -1238.043% |
| BioAtla, Inc. | -122.24 Million USD | 1285.709% |
| NLS Pharmaceutics AG | -11.79 Million USD | 12387.762% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | 9296.257% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | 582.669% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | 3597.049% |
| XOMA Corporation | -39.36 Million USD | 3782.287% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | 1560.316% |
| Cara Therapeutics, Inc. | -117.65 Million USD | 1331.978% |
| aTyr Pharma, Inc. | -52.17 Million USD | 2877.841% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | 1829.311% |
| Akero Therapeutics, Inc. | -148.63 Million USD | 1075.181% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | 717.919% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | 10716.143% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | 18122.481% |
| Akari Therapeutics, Plc | -16.8 Million USD | 8726.485% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | -767984.746% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | -220.706% |
| Lexaria Bioscience Corp. | -6.38 Million USD | 22787.542% |
| UroGen Pharma Ltd. | -63.83 Million USD | 2370.718% |
| Sutro Biopharma, Inc. | -67.91 Million USD | 2234.171% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | 20056.211% |
| Orgenesis Inc. | -60.71 Million USD | 2487.137% |
| Entera Bio Ltd. | -8.8 Million USD | 16563.221% |
| GH Research PLC | -41.15 Million USD | 3622.032% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | 5779.776% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | 1862.579% |
| Xencor, Inc. | -125.87 Million USD | 1251.486% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | 101703.665% |
| Replimune Group, Inc. | -230.19 Million USD | 729.641% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | 7290.443% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | 13346.408% |
| Lexaria Bioscience Corp. | -6.38 Million USD | 22787.542% |
| Portage Biotech Inc. | -18.19 Million USD | 8064.295% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | 94821.02% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | 1485.893% |
| OncoCyte Corporation | -23.12 Million USD | 6368.313% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | 12926.332% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | 12751.151% |
| Purple Biotech Ltd. | -22.22 Million USD | 6621.584% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | 22711.888% |
| scPharmaceuticals Inc. | -46.06 Million USD | 3246.745% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | 8238.393% |
| HilleVax, Inc. | -132.46 Million USD | 1194.184% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | 13731.355% |
| Tharimmune, Inc. | -9.3 Million USD | 15680.845% |
| Genprex, Inc. | -31.06 Million USD | 4766.438% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | 872.918% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | 4722.766% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | 189814.921% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | -960392.764% |
| OKYO Pharma Limited | -15.74 Thousand USD | 9205193.145% |
| Savara Inc. | -59.13 Million USD | 2551.122% |
| Curis, Inc. | -45.13 Million USD | 3311.019% |
| Daré Bioscience, Inc. | -30.7 Million USD | 4821.011% |
| Carmell Therapeutics Corporation | -15.19 Million USD | 9641.228% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | 20329.197% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | 5521.643% |
| BeiGene, Ltd. | -1.12 Billion USD | 228.882% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | 8991.505% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 436.619% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | 1704.408% |
| Erasca, Inc. | -121.31 Million USD | 1294.808% |
| bluebird bio, Inc. | -167.16 Million USD | 967.081% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | 32318.284% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | -367.128% |
| DBV Technologies S.A. | -85.98 Million USD | 1785.727% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | 32318.284% |
| Moderna, Inc. | -3.28 Billion USD | 144.149% |
| Vincerx Pharma, Inc. | -42.6 Million USD | 3501.68% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | 25762.571% |
| Molecular Templates, Inc. | 1.43 Million USD | -101258.182% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | 2521.677% |
| Travere Therapeutics, Inc. | -326.24 Million USD | 544.273% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | 1157.285% |
| Spruce Biosciences, Inc. | -47.36 Million USD | 3160.047% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | 1142.495% |
| Cogent Biosciences, Inc. | -205.86 Million USD | 804.081% |
| MacroGenics, Inc. | 2.01 Million USD | -71760.288% |
| RenovoRx, Inc. | -11.39 Million USD | 12825.391% |
| Adicet Bio, Inc. | -136.53 Million USD | 1161.575% |
| Prime Medicine, Inc. | -193.75 Million USD | 848.054% |
| Aditxt, Inc. | -25.45 Million USD | 5793.393% |
| Adagene Inc. | -14.95 Million USD | 9794.621% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 19927.669% |
| Quantum-Si incorporated | -91.8 Million USD | 1678.822% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | -103.454% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | -1046.196% |
| SciSparc Ltd. | -5.28 Million USD | 27540.78% |
| Vericel Corporation | 2.86 Million USD | -50508.31% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | 1522474.17% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | 6782.003% |
| Generation Bio Co. | -133.3 Million USD | 1187.338% |
| Astria Therapeutics, Inc. | -83.03 Million USD | 1845.661% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | 1784.924% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | 737.293% |
| Invivyd, Inc. | -196.61 Million USD | 837.188% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 487.388% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | 15727.532% |
| Spero Therapeutics, Inc. | 27.15 Million USD | -5237.784% |
| Artelo Biosciences, Inc. | -10.28 Million USD | 14192.581% |
| 2seventy bio, Inc. | -206.41 Million USD | 802.178% |
| ADMA Biologics, Inc. | 5.12 Million USD | -28209.023% |
| Clene Inc. | -43.24 Million USD | 3451.962% |
| Capricor Therapeutics, Inc. | -23 Million USD | 6399.376% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | 3089.917% |
| GeoVax Labs, Inc. | -26.66 Million USD | 5534.904% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | 583.841% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | 4046.223% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | -6048.653% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | -29418.263% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | 4562.231% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | 1015.016% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 311.809% |
| Evaxion Biotech A/S | -21.4 Million USD | 6872.051% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | 2282.371% |
| Verve Therapeutics, Inc. | -217.66 Million USD | 765.884% |
| Trevena, Inc. | -35.28 Million USD | 4207.408% |
| Surrozen, Inc. | -41.13 Million USD | 3623.916% |
| Tyra Biosciences, Inc. | -79.59 Million USD | 1921.065% |
| Cingulate Inc. | -22.95 Million USD | 6415.005% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | 19526.645% |
| Unity Biotechnology, Inc. | -37.28 Million USD | 3987.622% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | 17719.215% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | 1517.306% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | 2236.94% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | 2583.078% |
| Clearmind Medicine Inc. | -8.71 Million USD | 16739.63% |
| Kronos Bio, Inc. | -121.83 Million USD | 1289.709% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | 2049.668% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | 59468.137% |
| Viking Therapeutics, Inc. | -100.82 Million USD | 1537.534% |
| Statera Biopharma, Inc. | 38.93 Million USD | -3622.676% |
| ImmunityBio, Inc. | -436.18 Million USD | 432.298% |
| Korro Bio, Inc. | -80.9 Million USD | 1891.533% |
| Kineta, Inc. | -15.71 Million USD | 9323.762% |
| BioVie Inc. | -31.95 Million USD | 4636.503% |
| Codexis, Inc. | -49.28 Million USD | 3041.018% |
| Celularity Inc. | -183.94 Million USD | 887.961% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | 754.337% |
| Celcuity Inc. | -58.3 Million USD | 2585.72% |
| Virax Biolabs Group Limited | -6.6 Million USD | 22030.556% |
| Cibus, Inc. | -314.58 Million USD | 560.741% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | 4396.748% |
| IN8bio, Inc. | -28.5 Million USD | 5184.978% |
| Kodiak Sciences Inc. | -259.02 Million USD | 659.573% |
| Annexon, Inc. | -141.57 Million USD | 1123.784% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | 1387.242% |
| Assembly Biosciences, Inc. | -64.19 Million USD | 2357.807% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | 5284.84% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | 730.156% |
| Eyenovia, Inc. | -24.1 Million USD | 6112.693% |
| Puma Biotechnology, Inc. | 44.78 Million USD | -3136.473% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | 447452.469% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | 2063.88% |
| Arcellx, Inc. | -64.14 Million USD | 2359.602% |
| Cardiff Oncology, Inc. | -45.01 Million USD | 3319.936% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | 1273.849% |
| Regulus Therapeutics Inc. | -30.88 Million USD | 4793.42% |
| Moolec Science SA | -52.07 Million USD | 2883.307% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | 2908.631% |
| Geron Corporation | -174.78 Million USD | 929.274% |
| LAVA Therapeutics N.V. | -40.41 Million USD | 3686.169% |
| Royalty Pharma plc | 1.88 Billion USD | 23.2% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | 1311.962% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | 15644.643% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | 7088.28% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | 972.725% |
| Humacyte, Inc. | -96.45 Million USD | 1602.646% |
| Structure Therapeutics Inc. | -102.45 Million USD | 1514.636% |
| 89bio, Inc. | -134.46 Million USD | 1177.934% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | 1937.619% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | -35670.533% |
| Genelux Corporation | -24.16 Million USD | 6098.022% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | 4388.231% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | 986.692% |
| Notable Labs, Ltd. | -14.4 Million USD | 10165.431% |
| Liquidia Corporation | -70.05 Million USD | 2169.095% |
| Mustang Bio, Inc. | -48.06 Million USD | 3115.671% |
| Immunovant, Inc. | -269.97 Million USD | 636.867% |
| Quantum-Si incorporated | -91.8 Million USD | 1678.822% |
| Arbutus Biopharma Corporation | -70.98 Million USD | 2141.842% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | 7606.847% |
| Vera Therapeutics, Inc. | -102.01 Million USD | 1520.835% |
| Acasti Pharma Inc. | -11.3 Million USD | 12925.608% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | 6613.307% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | 9554.248% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | 788.519% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | 34041.583% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | 9227.343% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | 5136.913% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | 4014.183% |
| PepGen Inc. | -83.58 Million USD | 1834.132% |
| Moleculin Biotech, Inc. | -29.5 Million USD | 5012.629% |
| United Therapeutics Corporation | 1.38 Billion USD | -4.516% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 6430.183% |
| Solid Biosciences Inc. | -93.43 Million USD | 1651.279% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | 30475.151% |
| Immuneering Corporation | -58.06 Million USD | 2596.386% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | -45195472.186% |
| Silo Pharma, Inc. | -3.62 Million USD | 40070.669% |
| Belite Bio, Inc | -31.52 Million USD | 4697.107% |
| XOMA Corporation | -39.36 Million USD | 3782.287% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | 2248.979% |
| Bionomics Limited | -9.83 Million USD | 14834.398% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | 1825.811% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | 4288.355% |
| uniQure N.V. | -253.1 Million USD | 672.668% |
| Cassava Sciences, Inc. | -95.68 Million USD | 1614.753% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 19927.669% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | 1219.21% |
| Forte Biosciences, Inc. | -32.47 Million USD | 4562.919% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | 18104.184% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | 5236.334% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | 447452.469% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | 13109.802% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | 9215.288% |
| Altimmune, Inc. | -87.93 Million USD | 1748.288% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | 1674.107% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | 4288.355% |
| Compugen Ltd. | -12.51 Million USD | 11680.553% |
| Peak Bio, Inc. | -1356.23 USD | 106871500.869% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | 3082.473% |
| Benitec Biopharma Inc. | -22.49 Million USD | 6544.74% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 698.186% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | 5178.03% |
| Zura Bio Limited | -60.56 Million USD | 2493.247% |
| PolyPid Ltd. | -20.26 Million USD | 7253.047% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | 9383.43% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | 5178.03% |
| Instil Bio, Inc. | -146.12 Million USD | 1091.926% |
| argenx SE | -216.02 Million USD | 770.957% |
| Immunome, Inc. | -28.27 Million USD | 5226.886% |
| Compass Therapeutics, Inc. | -48.47 Million USD | 3090.164% |
| Verona Pharma plc | -52.46 Million USD | 2862.509% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | 1629.378% |
| Shattuck Labs, Inc. | -87.61 Million USD | 1754.308% |
| CervoMed Inc. | -2.17 Million USD | 66836.008% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | 1285.679% |
| Plus Therapeutics, Inc. | -12.69 Million USD | 11519.066% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | 3108.723% |
| Moolec Science SA | -52.07 Million USD | 2883.307% |
| Enveric Biosciences, Inc. | -17.13 Million USD | 8556.379% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | 1211.596% |
| AnaptysBio, Inc. | -143.16 Million USD | 1112.421% |
| Design Therapeutics, Inc. | -66.32 Million USD | 2285.333% |
| Leap Therapeutics, Inc. | -80.98 Million USD | 1889.697% |
| NeurAxis, Inc. | -6.66 Million USD | 21848.415% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | 3939.528% |
| Lumos Pharma, Inc. | -36.57 Million USD | 4063.418% |
| Achilles Therapeutics plc | -70.44 Million USD | 2157.611% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | 1629.378% |
| 180 Life Sciences Corp. | -22.13 Million USD | 6648.388% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | -24764.652% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | 59468.137% |
| Nutriband Inc. | -5.12 Million USD | 28399.202% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | 1420.682% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | 2714.775% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | 2967.304% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | 2320.418% |
| MoonLake Immunotherapeutics | -54.1 Million USD | 2778.661% |
| Palisade Bio, Inc. | -12.28 Million USD | 11902.15% |
| Tourmaline Bio, Inc. | -45.37 Million USD | 3294.248% |
| Beam Therapeutics Inc. | -156.47 Million USD | 1026.308% |
| Neurogene Inc. | -52.28 Million USD | 2872.103% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | 1161.925% |
| AEON Biopharma, Inc. | -48.36 Million USD | 3097.089% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | 1658.217% |
| Sesen Bio, Inc. | -50.84 Million USD | 2950.948% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | 1869.055% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | 11836.189% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 439.1% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | 1477.817% |
| Athira Pharma, Inc. | -116.7 Million USD | 1341.975% |
| Vaccinex, Inc. | -19.74 Million USD | 7439.589% |
| HCW Biologics Inc. | -23.57 Million USD | 6247.856% |
| XOMA Corporation | -39.36 Million USD | 3782.287% |
| Nektar Therapeutics | -243.1 Million USD | 696.207% |
| Arvinas, Inc. | -394.8 Million USD | 467.128% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | -767984.746% |
| Merus N.V. | -149.2 Million USD | 1071.417% |
| Omega Therapeutics, Inc. | -93.49 Million USD | 1650.35% |
| Quince Therapeutics, Inc. | -31.26 Million USD | 4736.667% |
| Rezolute, Inc. | -68.42 Million USD | 2218.326% |
| Clene Inc. | -43.24 Million USD | 3451.962% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | 9498.289% |
| BeyondSpring Inc. | -21.54 Million USD | 6828.979% |
| Synlogic, Inc. | -55.16 Million USD | 2727.621% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | 12095.547% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | 13719.827% |
| Peak Bio, Inc. | -1356.23 USD | 106871500.869% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | 4564.568% |
| Krystal Biotech, Inc. | 17.9 Million USD | -7995.521% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | 1323.936% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | 524.62% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | 31565.177% |
| MannKind Corporation | 15.12 Million USD | -9480.422% |
| Ikena Oncology, Inc. | -74.39 Million USD | 2048.226% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | 11609.744% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | -7030.526% |
| Gossamer Bio, Inc. | -172.15 Million USD | 941.943% |
| CohBar, Inc. | -12.06 Million USD | 12112.688% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | 5782.002% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | 4927.384% |
| Legend Biotech Corporation | -477.87 Million USD | 403.307% |
| Mural Oncology plc | -192.72 Million USD | 852.087% |
| Biora Therapeutics, Inc. | -114.05 Million USD | 1370.821% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | 9077.379% |
| Disc Medicine, Inc. | -91.02 Million USD | 1692.334% |
| Champions Oncology, Inc. | -5.05 Million USD | 28778.71% |
| REGENXBIO Inc. | -239.46 Million USD | 705.278% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | 13623.015% |
| Anavex Life Sciences Corp. | -55.75 Million USD | 2699.58% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | 3838.681% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | 1384.88% |
| Vaxart, Inc. | -74.72 Million USD | 2039.727% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | 4216.706% |
| Cellectis S.A. | -98.09 Million USD | 1577.57% |
| Longeveron Inc. | -20.06 Million USD | 7325.434% |
| Repare Therapeutics Inc. | -114.27 Million USD | 1368.385% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 430.017% |
| Inozyme Pharma, Inc. | -74.81 Million USD | 2037.419% |
| Revolution Medicines, Inc. | -430.58 Million USD | 436.619% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | 23146.939% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | 4807.597% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | 2043.185% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | -29461.942% |
| Anixa Biosciences, Inc. | -10.96 Million USD | 13318.623% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 68.526% |
| Denali Therapeutics Inc. | -179.97 Million USD | 905.355% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | 1522474.17% |
| Veru Inc. | -89.97 Million USD | 1710.906% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | 5492.596% |
| Cingulate Inc. | -22.95 Million USD | 6415.005% |
| Passage Bio, Inc. | -98.34 Million USD | 1573.874% |
| Context Therapeutics Inc. | -25.06 Million USD | 5883.675% |
| Exicure, Inc. | -15.53 Million USD | 9427.64% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | 803.384% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | 4019.899% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | 24408.573% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | 960.375% |
| Nuvalent, Inc. | -149.49 Million USD | 1069.565% |
| ABVC BioPharma, Inc. | -8.13 Million USD | 17922.775% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | 1787.454% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | 4902.909% |
| OmniAb, Inc. | -49.73 Million USD | 3014.524% |
| Anew Medical, Inc. | -1.3 Million USD | 111522.004% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | 11822.921% |
| Lipocine Inc. | -16.32 Million USD | 8979.812% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | 2274.024% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | 2050.691% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | 3900.943% |
| G1 Therapeutics, Inc. | -39.01 Million USD | 3815.133% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | 6633.931% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 365.915% |
| Ocugen, Inc. | -64.82 Million USD | 2335.831% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | 1665.758% |
| Q32 Bio Inc. | -86.5 Million USD | 1775.594% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | 8662.781% |
| Alumis Inc. Common Stock | -156.89 Million USD | 1023.846% |
| Equillium, Inc. | -12.13 Million USD | 12041.193% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | 2578.831% |
| Coya Therapeutics, Inc. | -7.9 Million USD | 18439.339% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | 7784.767% |
| Galera Therapeutics, Inc. | -46.69 Million USD | 3204.219% |
| Evelo Biosciences, Inc. | -106.34 Million USD | 1462.943% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | 8203.4% |
| Dominari Holdings Inc. | -22.44 Million USD | 6559.1% |
| Edesa Biotech, Inc. | -8.19 Million USD | 17797.153% |
| vTv Therapeutics Inc. | -25.41 Million USD | 5803.691% |
| Bio-Techne Corporation | 326.66 Million USD | -343.706% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 476.606% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | -569.822% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | 1205.518% |
| Candel Therapeutics, Inc. | -37.43 Million USD | 3972.25% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | 1059.241% |
| Nkarta, Inc. | -120.48 Million USD | 1303.03% |
| BioCardia, Inc. | -11.56 Million USD | 12638.253% |
| Iterum Therapeutics plc | -34.58 Million USD | 4291.504% |